文献速递肺外科

机器人辅助肺叶切除术治疗非小细胞肺癌:单中心综合经验

Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience.
PubMed 文献 · Ann Thorac Surg · 2019-04-18

该研究基于前瞻性手术数据库,比较2011至2017年831例非小细胞肺癌患者接受机器人辅助肺叶切除术(RAL)、电视辅助胸腔镜肺叶切除术(VAL)或开胸肺叶切除术(OL)的围术期与肿瘤相关结局,采用逆概率治疗加权调整。结果显示RAL与更长手术时间、更少出血和更优淋巴结清扫相关,住院时间较OL短,调整后费用无差异。

要点

  • RAL与VAL或OL相比淋巴结清扫更优且出血更少。
  • RAL住院时间短于OL,调整后费用与VAL无差异。
  • RAL患者特征更接近OL,提示经充分训练后典型开胸患者可接受微创手术。

核心结论

  • 机器人辅助肺叶切除术与更优淋巴结清扫和更少出血相关,住院时间较开胸短,调整后费用未增高。

研究设计与样本

  • 基于前瞻性手术数据库的回顾性队列研究,纳入2011至2017年831例非小细胞肺癌肺叶切除术患者,其中RAL 106例、VAL 301例、OL 424例。
  • 采用逆概率治疗加权(基于倾向评分的倒数)比较各手术方式结局。

主要发现

  • RAL患者接受新辅助治疗比例高于VAL(16% vs 6%,P = .001),但低于OL(28% vs 16%,P = .014)。
  • 调整后RAL与更长手术时间、更少出血和更优淋巴结清扫相关(均P < .02)。
  • 各手术方式间并发症、淋巴结升级或死亡率无差异。
  • RAL住院时间短于OL(P < .01)。
  • 未调整费用RAL高于VAL(P = .003),调整后费用差异消失。

临床怎么用

  • 对于非小细胞肺癌肺叶切除术,RAL可提供更优淋巴结清扫和更少出血,且住院时间较开胸短。
  • 经充分训练和经验积累后,RAL可使典型开胸患者接受微创手术。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: It is unclear whether the enhanced dexterity and visualization of the surgical robot lessens morbidity and influences staging or survival. We compared outcomes of robotic-assisted lobectomy (RAL) with thoracoscopic video-assisted lobectomy (VAL) or open lobectomy (OL) of non-small cell lung cancer. METHODS: Using a prospective surgical database, perioperative and cancer-related outcomes of patients who received a lobectomy for non-small cell lung cancer from 2011 to 2017 were analyzed. Outcomes between each surgical approach were compared using inverse probability of treatment weighting generated from the inverse of the propensity score. RESULTS: There were 831 patients: 106 RAL, 301 VAL, and 424 OL. More RAL patients than VAL received neoadjuvant therapy (16% vs 6%, P = .001), but less than OL (28% vs 16%, P = .014). After adjustment, RAL was associated with longer operative times, less blood loss, and improved nodal harvest (all P < .02). There were no differences in morbidity, nodal upstaging, or mortality between surgical approaches. Length of stay was shorter with RAL vs OL (P < .01). Unadjusted cost was higher after RAL vs VAL (P = .003), but after adjustment, cost differences disappeared. CONCLUSIONS: Robotic-assisted lobectomy was associated with improved nodal harvest and less blood loss as compared with VAL or OL. Length of stay was shorter with RAL as opposed to OL. Unexpectedly, cost was not higher with RAL. The profile of patients who received RAL more closely approximated OL, suggesting RAL may allow typical thoracotomy patients to receive minimally invasive surgery after adequate training and experience.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Nelson DB, Mehran RJ, Mitchell KG, et al. Robotic-Assisted Lobectomy for Non-Small Cell Lung Cancer: A Comprehensive Institutional Experience. Ann Thorac Surg. 2019. PMID: 31004583. doi:10.1016/j.athoracsur.2019.03.051

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。